July 10, 2026 · Form 4 insider transaction
Marks Gilbert Lynn bought 2,789 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.